Although Cdc42 expression remains unchanged compared to non-tumor tissue, we have found that its activity is directly correlated to reduced expression of FARP1, a guanine nucleotide-exchange factor (GEF), that activates Cdc42 (Croise et al., 2016). This evidence concerns the gene CDC42 and neoplasm.